venerdì, 4 dicembre 2020
Medinews
19 Ottobre 2018

Human medicine European public assessment report (EPAR): Blinatumomab Amgen

October 18, 2018 – This Human medicine European public assessment report (EPAR) was updated.
Leggi tutto

TORNA INDIETRO